Clinical trials
Recruiting Autism Spectrum Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
289 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 27 |
| 2023 | 51 |
| 2024 | 61 |
| 2025 | 69 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 289 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 18 |
| National Taiwan University Hospital | 9 |
| Riphah International University | 8 |
| Children's Hospital Medical Center, Cincinnati | 6 |
| Istituto per la Ricerca e l'Innovazione Biomedica | 5 |
| The Hong Kong Polytechnic University | 5 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Chang Gung Memorial Hospital | 4 |
| Children's Hospital of Fudan University | 3 |
| Emory University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autism Spectrum Disorder | 289 |
| Autistic Disorder | 91 |
| Neurodevelopmental Disorders | 26 |
| Intellectual Disability | 17 |
| Attention Deficit Disorder with Hyperactivity | 16 |
| Developmental Disabilities | 13 |
| Anxiety Disorders | 11 |
| Learning Disabilities | 10 |
| Bipolar Disorder | 6 |
| Fragile X Syndrome | 6 |
Trials
Showing 51 to 75 of 289. Each trial links to its page on Pharma Observatory.
189 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.